Because tirzepatide slows stomach emptying, large meals or high-fat foods consumed shortly after injection may sit in your stomach longer than usual, triggering nausea, bloating, or fullness that lasts hours
The SURPASS-1 trial investigated the efficacy and safety of the three doses of 5, 10, or 15 mg tirzepatide in drug-nave patients with T2D who were not sufficiently controlled with a lifestyle intervention with diet and exercise versus placebo (70)
Nausea is the most common symptom, affecting about 20 to 30 percent of patients during the first two weeks on Zepbound
Mounjaro contains the same active ingredient as Zepbound (tirzepatide) at identical doses but is FDA-approved for type 2 diabetes, not weight loss
Together, these stakeholders can ensure that medications like Semaglutide continue to play a vital role in improving the lives of those living with diabetes